Document Detail


RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells.
MedLine Citation:
PMID:  15314284     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
These studies explore the molecular effect of arsenicals on MM cells. Freshly isolated cells derived from patients with advanced, chemo-refractory myeloma as well as human myeloma cell lines, ARP-1, RPMI-8226 and H929 were exposed to the organic arsenical melarsoprol and to the inorganic compound AT. Both agents potently induced apoptosis in myeloma cells. Exposure to 1-5 microM AT or melarsoprol for 6 hours suppressed NF-kappa B DNA binding and enhanced of c-Jun kinase (JNK) activity. Arsenic also activated caspase-3 resulting in the cleavage of poly (ADP-ribose) polymerase (PARP) and Fas/TNF alpha related receptor interacting protein (RIP). In contrast to reported observations in acute promyelocytic leukemia, myeloma cell apoptosis was not associated with either the downregulation of Bcl-2 protein or with alterations in the expression of other Bcl-2 family members, Bax, Bak, Bag, and Bcl-xl. This study first shows that arsenic induces apoptotic signaling in MM through the cleavage of TNF alpha related receptor interacting protein (RIP). RIP is a key downstream protein in FasL/ TNF alpha /TRAIL induced apoptosis and a major antiapoptotic adaptor of pathways through NF-kappa B and JNK. RIP has not been previously characterized in myeloma. This study supports the hypothesis that arsenicals share common mediators (RIP, NF-kappa B, PARP, caspase-3) with death receptor induced apoptosis. These studies provide an important insight into the molecular mechanism of AT induced apoptosis and can be used in the development of adjuvant therapy for MM, presently an incurable disease.
Authors:
O Bajenova; B Tang; R Pearse; R Feinman; B H Childs; J Michaeli
Related Documents :
18080784 - Establishment of the expression system for studying the function of active caspase-3 in...
17339884 - Parthenolide protects human lens epithelial cells from oxidative stress-induced apoptos...
18281494 - Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated p...
11295044 - Apoptotic activity of novel bile acid derivatives in human leukemic t cells through the...
11319194 - Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine...
17114424 - Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Apoptosis : an international journal on programmed cell death     Volume:  9     ISSN:  1360-8185     ISO Abbreviation:  Apoptosis     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2004-08-17     Completed Date:  2005-04-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9712129     Medline TA:  Apoptosis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  561-71     Citation Subset:  IM    
Affiliation:
The Myeloma Service, Division of Hematology-Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. baj@bu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis / drug effects,  physiology*
Arsenic / pharmacology*
Caspase 3
Caspases / metabolism
Cell Division / drug effects
Cell Line, Tumor
Cell Survival / drug effects
Enzyme Activation / drug effects
Humans
Melarsoprol / pharmacology
Multiple Myeloma / pathology*
NF-kappa B / metabolism
Chemical
Reg. No./Substance:
0/NF-kappa B; 494-79-1/Melarsoprol; 7440-38-2/Arsenic; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Early anti-apoptosis treatment reduces myocardial infarct size after a prolonged reperfusion.
Next Document:  Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase...